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High-value claims against obstetricians in litigation in both the 
public and private sectors are mostly related to cerebral palsy (CP) 
cases on the basis of intrapartum hypoxia resulting in hypoxic-
ischaemic fetal brain damage and, by extension, invoking ‘negligent 
intrapartum care’. This development has resulted in steep rises in 
insurance premiums, placing service delivery under serious threat.[1] 
It is widely assumed that CP is the direct result of an adverse event 
during  birth and that it could have been prevented, yet only 10 - 14% 
of CP cases have been shown to be caused by intrapartum hypoxia.[2] 
Clinical epidemiological studies have shown that most cases of CP 
are not related to intrapartum hypoxia.[3,4] These studies, however, 
appear to be confined to high-income countries and are unlikely to be 
applicable to low- and middle-income countries (LMICs). The latest 
data  reported by the Perinatal Problem Identification Programme in 
the Saving Babies Report show that intrapartum hypoxia makes up 
24.3% of all neonatal deaths  where the birthweight was >500 g.[5] While 
accurate figures for intrapartum-related causes of CP in South Africa 
(SA) are not known, it is likely to follow that, with this large number 
of deaths owing to intrapartum hypoxia, the number of infants 
surviving such an insult with neurological damage will probably 
be substantially higher than in high-income countries. This view is 
supported by a retrospective study by Mahlaba et al.[6] where 144 
cases of CP were reviewed, of which 88 had neuroimaging reports 
and 42% of these showed evidence of hypoxic-ischaemic injury.
Numerous risk factors and causes are associated with CP.[3,4] We 
need to be careful not to oversimplify CP, which involves complex 
pathophysiological processes. Contributory variables incorporate 
failure of neurophysiological autoregulatory mechanisms, abnormal 
biochemistry and abnormal metabolic pathways. These are often 
juxtaposed with possible priming of the fetal brain on sometimes 
undetected antenatal insults such as fetal infection, inflammation and 
late-onset intrauterine growth restriction (IUGR) where hypoxia with 
cerebral redistributive mechanisms are already in place.[7] Placing this 
primed, compromised and compensated brain through the stresses 
of an intrapartum process could be the final straw in the pathway to 
brain injury and later CP.
Medico-legal cases involving CP in SA courts are mainly judged 
on magnetic resonance imaging (MRI) findings and cardiotocography 
(CTG) to assess causation and liability. Clinical notes are often 
missing, incomplete or inadequate, and Apgar scores are often 
inadmissible owing to falsification and late entries notwithstanding 
incomplete or lost information. Umbilical artery cord pH is generally 
not available in the State sector while, in the private sector, the 
BetterObs programme of the South African Society of Obstetricians 
and Gynaecologists in 2020 recommended umbilical artery cord 
pH sampling in all deliveries as standard of care to improve 
postnatal care and assist in causation in the event of hypoxic-
ischaemic encephalopathy (HIE). CTG has a false positive rate for 
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The science surrounding cerebral palsy (CP) indicates that it is a complex medical condition with multiple contributing variables and 
factors, and causal pathways are often extremely difficult to delineate. The pathophysiological processes are often juxtaposed on antenatal 
factors, genetics, toxins, fetal priming, failure of neuroscientific autoregulatory mechanisms, abnormal biochemistry and abnormal 
metabolic pathways. Placing this primed compromised compensated brain through the stresses of an intrapartum process could be the 
final straw in the pathway to brain injury and later CP. It is therefore simplistic to base causation of CP on only an intrapartum perspective 
with radiological ‘confirmation’, as is often the practice in medico-legal cases in South African courts. The present modalities (magnetic 
resonance imaging (MRI) and cardiotocography (CTG)), when available, that retrospectively attempt to determine causation in courts are 
inadequate when used in isolation. Unless a holistic scientific review of the case including all contributing clinical factors (antepartum, 
intrapartum and neonatal), fetal heart rate monitoring, neonatal MRI if possible (and preferred) or late MRI, and histology (placental 
histology if performed) is taken into account, success for the plaintiff or defendant currently in a court of law will depend on eloquent legal 
argument rather than true scientific causality. The 10 criteria set out in this article to implicate intrapartum hypoxia in hypoxic-ischaemic 
encephalopathy/neonatal encephalopathy serve as a guideline in the medico-legal setting.
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predicting CP of 60 - 99%,[8-10] and often invites biased attempts by 
expert witnesses at retrospective temporal reconstruction of a fetal 
condition with the outcome known. The predictive capability of CTG 
in neonatal encephalopathy (NE) is explored in the present article. 
Imaging of the brain has become an important tool in the drive to a 
better understanding of the timing and aetiology behind CP. It has 
been shown that the morphology of brain damage strongly relates to 
the stage of brain development at which the insult occurs. Two main 
patterns of hypoxic-ischaemic injury can be distinguished in the term 
neonate: these are the so-called acute profound (deep grey matter) 
and partial prolonged (watershed) lesions. Neuroimaging is further 
explored later in this supplement.
Neonatal encephalopathy: Evidence 
for antenatal factors, intrapartum 
factors, or both
Cowan and associates[12] showed that more than 90% of term 
infants with NE, seizures, or both, but without specific syndromes 
or major congenital defects, had evidence of perinatally acquired 
insults, with a low rate of established brain injury acquired before 
birth. The frequency of risk factors in infants with and without an 
established brain abnormality did not differ greatly, but the study was 
not designed to explore antenatal aspects of perinatal brain injury. 
Their data do not exclude the possibility that antenatal factors could 
initiate a causal pathway for perinatal brain injury and that they, 
possibly together with genetic predispositions to hypoxic-ischaemic 
injury, might make some infants more susceptible than others to the 
stresses of labour and delivery. Martinez-Biarge et al.[13] set out to 
determine whether antepartum factors alone, intrapartum factors 
alone, or both in combination, are associated with term neonatal 
encephalopathy. All cases that met the criteria for perinatal asphyxia 
had neuroimaging findings consistent with acute hypoxia-ischaemia, 
and had no evidence for a non-hypoxic-ischaemic cause of their 
encephalopathy. Controls were neurologically normal born infants. 
On logistic regression analysis in their study, only one antepartum 
factor (gestation ≥41 weeks) and  seven intrapartum factors 
(prolonged membrane rupture, abnormal CTG, thick meconium, 
sentinel event, shoulder dystocia, tight nuchal cord, failed vacuum) 
remained independently associated with HIE (overall 6.7% of cases 
and 43.5% of controls had only antepartum factors; 20% of cases 
and 5.8% of controls had only intrapartum factors; 69.5% of cases 
and 31% of controls had antepartum and intrapartum factors; and 
3.7% of cases and 19.7% of controls had no identifiable risk factors 
(p<0.001). The authors concluded that their results did not support 
the hypothesis that HIE is attributable to antepartum factors alone, 
but they strongly pointed to the intrapartum period as the necessary 
factor in the development of this condition. On the other hand, a 
large study by Badawi and colleagues,[14,15] investigating the presence 
of antenatal and intrapartum factors in infants with encephalopathy, 
concluded that, for most infants with this disorder, the causal 
pathway began before birth. Badawi et al.[14,15] reported that, in their 
distribution of risk factors for neonatal encephalopathy, only 4% 
related to intrapartum hypoxia only, 69% related to antepartum risk 
factors only, and in 25% was it related to a combination of antepartum 
risk factors and intrapartum hypoxia. Note that the Cowan study was 
not specifically designed to determine the role of antenatal risk factors 
in neonatal encephalopathy. The results between these two studies 
may be problematic to compare, owing to differing study populations 
and case definitions. In Gaffney’s study,[16] there was found to be an 
association between the quality of intrapartum care and CP, but this 
seems to have a role in only a small proportion of all cases of CP. The 
authors concluded that the role of adverse antenatal factors in the 
origin of CP needs further study. Volpe[17] found that where there is 
early-onset neonatal encephalopathy, the likelihood of intrapartum 
asphyxia remains high. Volpe comments that the ‘neurological 
syndrome’ that accompanies serious peripartum hypoxic-ischaemic 
cerebral injury is the prototype for neonatal HIE. He adds that in 
considering the nature and timing of hypoxia-ischaemia as the 
aetiology of neonatal HIE, three features are deemed to be important: 
(i) evidence of fetal distress and/or fetal risk for hypoxia-ischaemia 
(e.g. fetal heart rate abnormalities, sentinel event, fetal acidaemia); 
(ii) the need for resuscitation and/or low Apgar scores; and (iii) an 
overt neonatal neurological syndrome in the first hours or day of life.
Fetal priming
Fetal priming may play a leading role in perinatal brain injury. 
Priming creates a vulnerability and susceptibility to the stresses of 
the intrapartum process which may be the final straw in the pathway 
leading to HIE.
Inflammation and neonatal encephalopathy
Most cases of CP (but not necessarily NE) are due to antenatal factors 
recognised in human epidemiological studies[3,4] which act in synergy 
with each other to create a disturbance, and often prime the fetal 
brain for hypoxia, with the intrapartum period being the final straw. 
The labour process is ‘hypoxic-centric’ as blood flow to the fetus 
diminishes with each contraction. A physiologically normal fetus has 
adequate reserve to overcome this, but with fetal priming this reserve is 
diminished, exposing the fetus to hypoxic damage. Inflammation and 
maternal fever caused by chorioamnionitis or urinary tract infections 
are now well-recognised subacute or acute factors frequently associated 
with NE at birth and with CP risk in several studies regarding 
preterm, near-term or full-term infants.[18-22] In a study of full-term 
newborns who had CP, 38% of spastic quadriplegias were associated 
with chorioamnionitis.[23] Many studies have linked the close 
associations between perinatal infections and hypoxic-ischaemic 
insults to the brain and could convert a minor hypoxic stimulus 
insult into a seriously damaging event intrapartum in the event of 
fetal brain priming.[24-27] Recent evidence suggests that inflammatory 
phenomena play a more significant role in the aetiology of brain 
lesions common in CP.[24-27] A recent study in Uganda[28] showed 
that maternal and newborn infection, and inflammation based 
on blood cultures, molecular assays and placental histology, are 
independent risk factors for NE. The strongest associations were seen 
with fetal inflammation (funisitis) and early neonatal bacteraemia, 
supporting a role in the aetiological pathway of term brain injury. 
Increasing evidence suggests the critical importance of a sensitising 
effect of inflammation in the pathogenesis of NE.[29,30] There is also 
evidence of a protective effect of maternal chorioamnionitis in 
neonates as regards neonatal brain injury. It is possible in some cases 
that chorioamnionitis may have had a pre-conditioning effect that 
protected the neonate against brain injury.[31] There can thus be both 
a sensitising and protective effect, depending on the interval between 
the inflammation stimulus and the hypoxic event.
Placental-mediated disease
Placental-mediated disease can result in hypoxia or fetal priming 
for hypoxia, with some degree of IUGR present when labour starts. 
Two types of IUGR are recognised – early onset and late onset: at 
<34 weeks’ gestation, the IUGR is regarded as early onset, and after 
34 weeks as late onset.[32,33] Placental-mediated disease is due to 
abnormalities in placental implantation and transformation (degree, 
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if any, of trophoblastic invasion of the spiral arterioles), and results 
in a phenotype that will be diagnosed later in pregnancy. The 
phenotype can encompass multiple conditions including IUGR, 
pre-eclampsia, combined IUGR and pre-eclampsia, stillbirth or 
abruptio placentae.[34] The main pathogenesis of the placental 
maladaptive process is placental arteriolar vasoconstriction that 
results in perfusion abnormalities leading to placental ischaemia 
and necrosis. This is generally true for early-onset IUGR where the 
cascade of cardiovascular deterioration is predictive. In this scenario, 
fetal adaptation sets in early, resulting in a small fetus and predictable 
Doppler velocimetry or flow velocity anomalies.[35] However, in late-
onset IUGR, the pathogenesis is mostly related to placental diffusion 
anomalies and, in this scenario, diagnosis can be elusive as the fetuses 
are not necessarily small and umbilical artery Doppler velocimetry 
(which is the premier fetal vessel of investigation in IUGR), is often 
normal. The only method of diagnosing hypoxia in late-onset IUGR 
fetuses is by the middle cerebral artery Doppler velocimetry, which 
reveals arterial redistribution.[36] In the presence of fetal hypoxia, 
the fetus sets into motion fetal redistributive mechanisms as a 
compensatory measure to protect vital organs including the brain, 
heart and adrenal glands. Thus, in late-onset IUGR, if one has not 
investigated the cerebral circulation, hypoxia can be missed and the 
fetus will enter the intrapartum process primed for hypoxic brain 
injury. Thus, often irrespective of intrapartum management (which 
could be optimal), the stressful process of labour will compromise 
this fetus. Furthermore, the devastating condition of ‘unexplained’ 
stillbirth in the late third trimester is often due to undiagnosed late-
onset IUGR, and these fetuses which may fall within the normal 
weight range die owing to severe hypoxia and acidosis as a result 
of acute placental failure.[7,37] A normally grown fetus with normal 
metabolic demands that is subjected to acute placental failure and 
thus acute hypoxia is probably more at risk of a stillbirth/neurological 
impairment than an early-onset chronic growth-restricted process 
where fetal adaptation has set in.
Placental histological examination may contribute significantly to 
determining the aetiology of apparent hypoxia-related CP. Placental 
lesions decrease the threshold for brain injury.[38] Placentas with 
decreased reserve may be unable to function adequately during labour. 
Multiple early and late insults can act together to increase the risk of 
perinatal brain injury. Contributory factors where placental histology 
can help to focus on the aetiology include findings of chorioamnionitis 
with severe fetal inflammatory response, diffuse villous oedema 
and multiple inflammatory placental lesions. Redline produced a 
placental classification incorporating the 2014 Amsterdam Placental 
Workshop group criteria.[39] Placental pathologies relevant to CP 
include: (i) sentinel lesions – abruptio placentae, fetal haemorrhage, 
umbilical cord occlusions; (ii) thrombotic or inflammatory lesions of 
fetal circulation – fetal vascular malperfusion, severe chronic villitis, 
meconium-associated vascular necrosis, chorioamnionitis with severe 
fetal vasculitis;  (iii) decreased placental reserve – maternal vascular 
malperfusion, diffuse chronic villitis, chronic abruption, chronic fetal 
vascular malperfusion, massive perivillous fibrin deposition; and (iv) 
adaptive responses in the placenta – increased nucleated red blood 
cells, villous chorangiosis, and distal villous immaturity.[40]
Diabetes
Another important cause of fetal priming is a metabolically unstable 
fetus in maternal diabetes. The concept of a pseudo-hypoxic state is 
based on the fact that fetal hyperinsulinaemia in diabetes results in 
an increased metabolic rate, leading to increased glucose oxidation 
and oxygen consumption. The capacity for oxidative metabolism is 
generally limited in all fetuses owing to low pyruvate dehydrogenase 
activity and, in a fetus of a diabetic pregnancy, this capacity is further 
reduced and thus increasing the risk for anaerobic metabolism 
irrespective of the prevailing levels of oxygen in the fetal circulation, 
leading to an increased risk for fetal acidosis.[41,42] The high incidence 
of nucleated red blood cells and polycythaemia (which are markers for 
hypoxia) in diabetic infants could reflect tissue hypoxia and fits well 
with the hypothesis of a ‘pseudo-hypoxic state’ in the fetus.[42,43] These 
fetuses are primed for hypoxia well before the intrapartum process. 
Risk factors in these fetuses would be macrosomia, polyhydramnios 
and abnormal cardiac function.[41,42] These fetuses are at higher 
risk of delivery complications, hypoglycaemia and acquired brain 
injury. In late-booked patients (those who first attend antenatal care 
late in pregnancy), for example, the glucose tolerance status may 
not be known, yet this fetus could well be primed for a damaging 
intrapartum hypoxic episode, especially in patients with an increased 
body mass index.
Toxic factors, maternal factors, postmaturity
Among toxic factors, alcohol is one of the most frequent which could 
determine brain maldevelopment during the whole pregnancy and 
later CP in case of severe malformation such as lissencephaly.[44] In 
animal studies, it was observed that it is an additional factor which 
aggravates damage induced by an acute ischaemic or excitotoxic 
event.[45] Other drugs such as cocaine and even tobacco smoking 
are implicated. An increasing number of drugs such as valproic acid 
taken by the mother during gestation are shown to interfere with 
brain energy, transfer of carbon monoxylic acid and carbohydrate 
and lipid metabolisms. This alteration may not be transitory but can 
permanently impair neuronal function and contribute to postnatal 
neurological disease including CP.[46] One could hypothesise fetal 
brain priming by toxic factors on the basis of altered metabolic 
pathways making them vulnerable to intrapartum hypoxic brain 
damage. In post-term birth, placental involution and dysfunction make 
the brain sensitive to damage.[15] Maternal factors such as maternal 
thyroid disease have been related to neonatal encephalopathy and CP 
in full-term infants. Antiphospholipid syndrome and systemic lupus 
erythematosus on the basis of a vasculopathy can also be implicated.[47]
Implications for liability of healthcare 
workers
It needs to be accepted that underlying priming antepartum factors 
may present with intrapartum evidence of fetal hypoxia and should 
be detectable on monitoring. If a vulnerable fetus is hypoxic on 
admission, this needs to be detected and dealt with appropriately. 
Where the underlying factor is undetected and the labour is considered 
low-risk, standard monitoring with intermittent auscultation should 
be able to detect decelerations. Decreased baseline variability will, 
however, be difficult to assess with intermittent auscultation. An 
underlying vulnerability is not an excuse for healthcare workers who 
do not follow standard monitoring practice. Nevertheless, the degree 
of vulnerability and how soon a pregnant woman presents to the 
labour ward will ultimately determine the severity of the hypoxic-
ischaemic process that may already be under way. Irrespective of 
intrapartum management, subsequent NE/CP may be unavoidable. 
Genetics
Genetic polymorphisms may increase the risk or severity of 
neonatal brain injury in NE and should be considered.[48] An 
increased risk of CP has been observed in some families in a 
national Swedish database.[49] Gene factors are involved in some 
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thrombophilias underlying perinatal strokes and secondary CP.[50] 
Genetic polymorphisms in gene-encoding proteins of inflammation 
or coagulation or vascular endothelium of the placenta are associated 
with CP in some children.[50] Recent investigation of genetic causes in 
a large cohort of singleton CP cases shows that the proportion 
of the cases carrying plausible genetic mutation is much larger than 
previously thought. At least 14% of nearly 200 singleton cases with 
CP studied have been found to have a plausible genetic mutation, 
de novo or inherited.[51] A further 44% had candidate variants that 
are yet to be resolved in regard to their causation of the CP. The 
percentage of cases with a genetic mutation is likely to rise as larger 
cohorts are studied, new CP genes are discovered, and whole genome 
sequencing is routinely performed. It is also now important to 
consider possible genetic causes that may directly, or through genetic 
susceptibility, trigger different pathways to different neuropathologies 
that share the common clinical trait of a nonprogressive movement 
disorder diagnosed as CP. In the near future, it will be possible to test 
for many of the putative or validated genes that have been associated 
with CP to date. This panel of different pathogenic genetic variations 
contributing to the CP spectrum is very likely to grow over the next 
decade, and should open a new direction into the causes of CP and 
challenge previous medico-legal assumptions about the culpability of 
the accoucheur.
Neuroimaging
Neonatal MRI can help evaluate brain injury and identify infants 
at risk for CP, and also assists in establishing timing of the injury 
depending on when it is performed. Two main patterns of hypoxic-
ischaemic injury can be distinguished in the term neonate.[52] These 
are the so-called acute profound (deep grey matter) and partial 
prolonged (watershed) lesions. The acute profound injury follows 
abrupt-onset near-total asphyxia of short duration (sentinel events), 
where there is no time for compensatory redistribution of blood 
flow from the cerebral hemispheres to the life-preserving deep grey 
matter (predominantly basal ganglia and thalamus). Examples of 
sentinel events resulting in the acute profound injury pattern are 
ruptured uterus, abruptio placentae, cord prolapse and sudden-onset 
fetal bradycardia of unknown origin.[53-55] The partial prolonged 
brain injury pattern involves the vascular watershed zones affecting 
cerebral white matter and the overlying cortex. This injury follows 
vascular redistribution with sacrifice of the parasagittal regions and 
sparing of the deep grey matter in response to ongoing cerebral 
hypoxia-ischaemia, with the duration of injury measured in hours 
rather than minutes. Intermediate, combined and other injury 
patterns are also observed. These injuries are best distinguished in the 
neonatal period but remain discernible into adulthood, as the effects 
on the brain are static and permanent. Neonatal MRI is rarely available 
in low-resource settings, forcing a dependence on MRI in childhood 
or adolescence where the findings invite retrospective efforts to 
implicate clinical events and their timing. ‘Acute profound’ and ‘partial 
prolonged’ brain lesions are often used retrospectively to ‘diagnose’ 
and implicate clinical events and scenarios. If the MRI is performed 
beyond three weeks post delivery, it cannot on its own delineate if 
the injury occurred during labour or within days before labour and 
delivery.[11] Imaging abnormalities suggestive of hypoxic-ischaemic 
injury need to be correlated, where possible, with the known sequence 
of events during pregnancy, childbirth and infancy. These radiological 
descriptions are probably accurate in describing the neurological 
ischaemic insult but less accurate in extrapolating this to aetiology, 
causation and timing. Much of the data describing these lesions are 
from animal model studies involving vascular occlusion techniques 
but there are also many human studies that have corroborated these 
types of lesions in the acute hypoxic setting.[53-55] The evolution of 
these lesions as described by the radiological findings has merit but 
it is doubtful that a direct extrapolation to the labouring mother in 
the maternity ward can always be made. Furthermore, to judge cases 
from a purely radiological perspective without giving clinical context, 
diminishes the value and sensitivity of the modality to predict 
causation. Even if these lesions are seen, they may not necessarily 
represent events solely in the intrapartum period – in many instances, 
the intrapartum period is just the final straw on an already hypoxic 
primed fetus from antenatal factors. The clear distinction between 
these two descriptions are in many cases in the clinical setting 
not clear-cut, with a mixed picture described, making aetiological 
determination difficult.
Although the acute profound injury pattern is linked to a clinical 
incident or process, namely a sentinel event, the central grey nuclei 
injury may also occur in the absence of clinically obvious sentinel 
events and this is well-described in the literature.[53] A single sudden 
hypoxic event of unknown cause, presenting as an acute onset of fetal 
bradycardia in a monitored fetus, can result in an ‘acute profound 
picture’.[53,55] Animal experiments involving intermittent so-called 
sub-threshold hypoxic episodes over several hours have produced 
similar brain injuries, as reviewed by Gunn and Bennet.[56] However, 
these repeated episodes of 5 - 10 minutes of profound hypoxia are 
not plausible proxies for occurrences in normal or abnormal human 
labour.
Although neuroimaging studies have made significant 
contributions to our understanding of CP, many are less informative 
than they might be because of four common problems: (i) ascription 
of aetiology to anatomic findings; (ii) inconsistent description of 
pathological findings; (iii) inconsistent anatomical findings and brain 
timing insult estimates; and (iv) studies not based on generalisable 
samples.[57]
MRI can provide mutual information from diffusion-weighted 
imaging, conventional imaging, and magnetic resonance 
spectroscopy, which can inform timing. Information regarding the 
likely timing is best obtained with early imaging (first 24 - 96 hours 
of life) with further follow-up imaging to define the full nature of 
the abnormalities, optimally at 10 days of life (but with an acceptable 
window between 7 days and 21 days of life, depending on the logistics 
of acquiring MRI in the clinical setting).
However, even if the MRI has been done long after the event, the 
information cannot be dismissed. The injury is in any case a one-off 
and does not progress, and the chronic evolution seen months or 
years later is well understood and shows typical features on MRI. 
This evidence, however, has to be interpreted in the context of the 
sequential clinical data, noting that the fetus was well at onset of 
labour, and then fetal heart rate anomalies developed, followed by low 
Apgar scores postnatally and then HIE.
In LMIC settings, we have to accept that the norm would be the late 
MRI, usually during childhood. Such MRI scans can also be of value. 
In fact, they can show abnormalities, or normality, not consistent with 
hypoxic-ischaemic injury. They can show basal ganglia-thalamus-
type injuries that suggest sudden-onset injury (‘acute profound’) 
that are usually not amenable to obstetric interventions. When 
they show cerebral watershed injury with or without deep nuclear 
injury (partial prolonged), a range of explanations will be possible, 
where correlation with clinical findings is important. Timing of 
lesions in the late MRI predicting when the insult occurred, will 
always, however, be an issue. It will be the duty of the obstetrician 
to correlate the MRI with what happened. Therefore the retention of 
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good clinical notes reflecting clinical data is crucial in this scenario. 
It is unacceptable in these cases for the radiological perspective to be 
viewed in isolation without giving clinical context to the radiological 
findings. Medico-legal decisions should be based holistically on 
the clinical data and the radiology, interpreted in the context of the 
clinical scenario. Otherwise, success of litigated cases will depend on 
eloquent legal argument rather than a cogent scientific argument. It 
needs to be noted that lack of accurate reliable documentation and 
absence of adequate monitoring make apparent practice difficult to 
defend where, in fact, the care may have been in fact optimal.
The debate circa CTG
The CTG is the cornerstone of intrapartum fetal monitoring, used 
for the past four decades and is unlikely to be replaced soon. The 
CTG is also used frequently in the medico-legal setting to pronounce 
on cases. Owing to its subjective nature and large inter-observer 
and sometimes intra-observer variability, CTG interpretation has 
become a contentious issue. The CTG is used retrospectively, with 
the outcome already known to temporally reconstruct the adverse 
event and is therefore often open to bias. There are differing strong 
opinions on each side of the debate for the CTG and we will attempt 
here to give a balanced view on its use. Current data show that use 
of the CTG during labour results in no significant differences in 
rates of CP, infant mortality or other standard measures of neonatal 
well-being as reviewed by the Cochrane Library,[7] by NICE[58] and 
FIGO,[59] but has been associated with an increase in caesarean 
sections and instrumental vaginal births. The CTG is also accepted 
as having a 60 - 99% false positive rate in predicting CP.[8,9] On 
the other hand, Witznitzer,[60] Chen et al.,[61] and Vintzileos[62] 
have different opinions. Witznitzer concluded that electronic fetal 
monitoring has a biologic basis on supporting research (although 
most studies are underpowered or have not defined appropriate study 
variables or outcomes), and there is evidence that, when utilised as 
part of an ongoing quality improvement programme, this results in 
improved neonatal outcome. Witzniter has also commented that more 
research is needed to define the use of electronic fetal monitoring 
in appropriate target populations, in determination of neonatal 
outcome, in utilisation with other measures of fetal functioning, and 
in quality improvement and education programmes. Vintzileos 
proposes that longitudinal fetal heart rate changes rather than a 
cross-sectional assessment should be used to detect intrapartum 
hypoxia. Chen et al.[61] in a retrospective study, examined the 
association between electronic fetal heart rate monitoring and 
neonatal and infant mortality, as well as neonatal morbidity. The 
primary finding of the study was that electronic fetal monitoring 
use during labour was associated with a significant decrease in early 
neonatal and infant mortality. However, the good outcomes may not 
necessarily be the result of CTGs but of other confounders. Newer 
studies have linked neonatal acidaemia with intrapartum fetal heart 
rate patterns. Toomey et al.[63] showed that tachycardia in the last two 
hours of labour was most specific in predicting neonatal acidaemia 
while total decelerations (variable and late) were most sensitive. 
They found that acidaemic neonates were more likely to have CTGs 
having >11 late decelerations, >15 total decelerations and at least 
80 minutes of tachycardia in the last 2 hours of labour. Williams 
et al.[64] reported that the most significant intrapartum fetal heart 
rate parameter to predict development of significant acidaemia is the 
presence of minimal/absent variability for at least an hour as a solitary 
abnormal finding. It needs to be stated, however, that the finding of 
acidaemia does not always equate to CP. They also found that fetuses 
with normal variability and accelerations even in the presence of late 
decelerations and/or variable decelerations maintained an umbilical 
artery pH >7 in more than 97% of cases. Rosenbloom et al.[65] 
reported umbilical arterial lactate levels at birth in a nested case-
control study within a prospective cohort of labouring mothers at 
term who achieved active labour. Neonates with umbilical arterial 
lactate >4 mmol/L (cases) were matched 1:1 to controls with lactate 
<4 mmol/L. Electronic fetal heart rate monitoring patterns were then 
compared by multivariable logistic regression. They reported no 
differences in electronic fetal monitoring (EFM) parameters in the 
first 60 minutes after admission. At the beginning of active labour, 
13.5% of cases and 26.1% of controls had always normal tracings. 
Cases were therefore less likely to have an always normal tracing 
from admission to the active phase. The researchers concluded that 
elevated umbilical arterial lactate at birth is associated with distinct 
EFM patterns early in the course of labour. A review of 12 trials 
(37 000 deliveries) comparing continuous CTG during labour with 
intermittent fetal heart auscultation found that the relative risk of 
neonatal seizures in low-risk women was significantly lower in women 
undergoing continuous monitoring (relative risk (RR) 0.36, 95% 
confidence interval 0.16 - 0.81) but had no effect on the incidence of 
paediatric neurological morbidity, CP or perinatal death.[66] This effect 
seems greater in women with low-risk pregnancies, probably because 
CTG facilitates earlier detection of fetal distress, thus allowing 
timely delivery. Others, however, reported some concerns regarding 
these 12 RCTs, covering 37 000 women. Only 2 of these trials were 
of high quality and only 3 trials reported data in low-risk women. 
The combined sample size of 12 RCTs is insufficient to determine 
whether EFM can significantly lower neonatal mortality or reduce 
the risk of intrapartum-related CP. Alfirevic et al.,[9] noted that to test 
the hypothesis that continuous monitoring can prevent 1 death in 
1 000 births, more than 50 000 need randomisation.
There are polarised views on the use of the CTG intrapartum but 
we believe that introducing standardised guidelines in interpretation 
will improve its use and sensitivity to detect hypoxia-ischaemia. 
Standardised guidelines, for example those by Macones et al.,[67] 
may also ensure fairness in the medico-legal setting, where strong 
personal expert opinion often wins the day rather than appropriate 
interpretation according to accepted criteria. It needs to be noted 
that many cases of NE and CP occur in so-called ‘low-risk patients’. 
However, in the SA setting, according to Department of Health 
guidelines, CTG is not recommended for low-risk labour but rather 
intermittent auscultation is recommended before and immediately 
after contractions. CTG monitoring is not recommended for 
intrapartum use in community health clinics. CTG is recommended 
only for high-risk labour, such as previous caesarean section, 
suspected IUGR, multiple pregnancy, pre-eclampsia, antepartum 
haemorrhage, premature rupture of membranes, suspected 
chorioamnionitis, meconium-stained liquor, poor progress in labour 
and oxytocin infusion.[68] The National Institute for Health and Care 
Excellence (NICE) recommends that continuous monitoring of the 
fetal heart with CTG should be restricted to high-risk labour. This is 
in keeping with most guidelines internationally. We have to accept at 
the present moment that the CTG, irrespective of the problems and 
issues, remains the cornerstone of intrapartum monitoring, but we 
need to understand its usefulness and limitations.
The three-tier fetal heart rate interpretation (as presented by 
the National Institute of Child Health and Human Development 
Workshop Report[67] (http://samj.org.za/public/sup/15399-1.pdf)) is 
helpful and which the authors accept should be used for conformity 
and consistency, i.e. Grade 1 is normal, Grade II is indeterminate and 
Grade III is abnormal. It is the grade II CTGs which are indeterminate 
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and account for >80% of cases[67] and that are difficult to predict 
fetal acid-base status at observation as they are quite variable ,from 
most benign to most threatening, but are also very subjective, 
especially interpretation of FHR variability. An advance in this 
regard is the Vintzileos proposition[62] to recategorise some grade II 
tracings where any pattern of decelerations that cause compensatory 
tachycardia should be included in the list of clinically significant 
decelerations. Grade I CTG, i.e. the normal CTG, is useful in that 
it is strongly predictive of normal acid-base balance at the time 
of observation. Grade III CTG is abnormal, showing a sinusoidal 
pattern or absent variability with recurrent late decelerations, recurrent 
variable decelerations, or bradycardia. This is strongly predictive of 
abnormal fetal-acid base status at the time of observation. Depending 
on the clinical situation, efforts to expeditiously resolve the underlying 
cause of the abnormal fetal heart rate pattern should be made. In such 
cases, regardless of variability, there is correlation between severity 
and duration of bradycardia and fetal acidaemia at birth with time to 
delivery thresholds  being 25, 13, 8, 6 and 5 minutes for bradycardias 
at 80, 70, 60, 50 and 40 bpm, respectively.[69] Vintzileos[62] also states, 
in keeping with the concept of priming, that fetuses with reduced 
fetal reserve should be taken into consideration especially in the 
interpretation of category II fetal heart patterns, where antenatal 
factors play a significant role in reducing thresholds for brain injury 
intrapartum.
Criteria for implicating intrapartum 
hypoxia in neonatal encephalopathy
The Cerebral Palsy Expert Task Force comprising the American 
College of Obstetrics and Gynecologists and the American Academy 
of Pediatrics in the first edition of their report outlined criteria which 
they regarded essential to trying to establish a causal link between 
intrapartum hypoxic events and CP. Depending on the nature and 
timing of the brain injury, it is now known that there are multiple 
potential pathways that can lead to CP in term infants, and the signs 
and symptoms of NE may range from mild to severe. Consequently 
a revision in 2014[11,70] of the criteria set out in 2003, took into 
account a broader perspective. It is also acknowledged that there are 
knowledge gaps which may still preclude a definitive set or set of 
markers that accurately identify with high sensitivity and specificity 
an infant in whom NE is attributable to an intrapartum event. Distal 
risk factors (DRFs) and proximal risk factors (PRFs) are described 
in their causal pathways. DRF implies a pathogenic effect exerted 
on fetal brain development which begins at a time remote from the 
onset of irreversible brain injury, e.g. some placental anomalies, 
genetic anomalies, and environmental and sociodemographic factors. 
PRF implies a pathogenic effect on the fetal brain development at a 
time that closely predates or coincides with the onset of irreversible 
brain injury, e.g. acute chorioamnionitis and abruptio placentae. 
Interestingly, it has also been noted that both DRF and PRF factors 
can occur in the same patient, leading to NE. NE may or may not be 
seen after birth when the brain injury or anomaly occurs at a time 
remote from the delivery process. It is also noted that a brain insult 
may occur at multiple points during gestation. The neonatal period 
may also be susceptible to brain injury following a predisposing distal 
risk factor. So there can be many permutations in the causality of an 
acute hypoxic brain insult. A revised version  by the Cerebral Palsy 
Expert Task Force proposed that a multidimensional, comprehensive 
and holistic assessment be performed of the neonatal status and all 
potential contributing factors. These must include maternal medical 
history, antenatal risk factors, and intrapartum factors (including 
fetal heart rate monitoring results and factors  relating to the delivery 
itself) in order to establish the likelihood that an acute hypoxic- 
ischaemic event occurred within close temporal proximity to labour 
and delivery which could have contributed to NE.
Most neonates with HIE develop fetal distress without a sentinel 
event. There could be a combination of causes in an individual 
neonate (variables not always completely understood) but the clinical 
response must be to act accordingly in those fetuses deemed to be at 
risk of injury to prevent this, based on either antepartum risk factors 
and/or intrapartum factors, e.g. abnormalities in the fetal heart rate 
monitoring and/or delays in progession of the intrapartum process. 
A fetus can have several factors that make it susceptible to injury 
but appropriate management may prevent that from happening. 
In this regard, Bothma and Buchmann[71] stated that there appears 
to be a failure to detect or respond to evidence of fetal distress 
even in facilities with skilled staff and available resources. In SA, 
the incidence of fresh stillbirths weighing 2 500 g or more seems 
to be unacceptably high, even in secondary and tertiary referral 
institutions. Fresh stillbirths in this birthweight category should be 
rare, but 35% of fresh stillbirths in SA are in this category, with 
the leading primary obstetric cause of death being intrapartum 
asphyxia and birth trauma.[71] The root of the problem seems 
to be a failure to detect evidence of fetal distress, especially in 
labours that appear uncomplicated. This leads one to conclude that 
there is a significant role for improving labour-related care and 
ability to timeously detect compromise during labour, whatever 
the causal pathway. Buchmann and Velaphi[72] wrote that there 
has been a general decline in rates of intrapartum hypoxia and its 
consequences, especially in developed countries. However, a large 
enquiry may be an important vehicle for providing information 
to help prevent HIE and intrapartum-related perinatal death in 
the local setting. Although antenatal factors may play a role in 
pathogenesis of NE, optimal intrapartum care would in many 
instances avoid hypoxic brain injury.
Criteria used to implicate acute intrapartum hypoxia in NE by 
the American College of Obstetricians and Gynecologists (ACOG) 
Task Force on Neonatal Encephalopathy and Neurological Outcome 
(2014)[11,70] are accepted by the present authors and are enumerated 
below, but we have added comments after each criterion to reflect 
the SA experience and make them more relevant to our setting, and 
a 10th criterion, that of placental histology, has also been added. We 
consider any intrapartum hypoxic event, whether sentinel or more 
prolonged, to be ‘acute’ as used in the wording of the ACOG Task 
Force. A summary of the criteria is presented in Fig. 1. If most of the 
criteria are met, this will implicate intrapartum hypoxia as causative 
of the HIE; however, if most of the criteria are not met then it would 
be unlikely that intrapartum hypoxia can be implicated in the HIE.
Summary of criteria to implicate 
intrapartum hypoxia in NE[11,70]
1. Case definition: NE is a clinically defined syndrome of disturbed 
neurological function in the earliest days of life in an infant born 
at or beyond 35 weeks’ gestation, manifested by a subnormal level 
of consciousness or seizures, and often accompanied by difficulty 
with initiating and maintaining respiration and depression of tone 
and reflexes.
Comment: Accepted as is.
2. Apgar score: Low Apgar scores at 5 minutes and 10 minutes clearly 
confer an increased RR of CP. The degree of Apgar abnormality at 
5 minutes and 10 minutes correlates with the risk of CP. However, 
most infants with low Apgar scores will not develop CP. There are 
many potential causes for low Apgar scores. If the Apgar score at 
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5 minutes is ≥7, it is unlikely that peripartum hypoxia-ischaemia 
played a major role in causing NE.
Comment: This is a subjective assessment and can often be shown 
to be incorrect retrospectively based on the clinical markers entered 
in the case notes. Unfortunately, it is also known that falsification 
of Apgar scores occurs, leading to their inadmissibility. Also, most 
infants with low Apgar scores will not develop CP.
3. Umbilical artery cord pH: Fetal umbilical artery cord pH <7.0, or 
base deficit ≥12 mmol/L, or both, increases the probability that NE, 
if present, was as a result of an intrapartum hypoxic event; lesser 
degrees of acidaemia decrease that likelihood. Umbilical venous 
(UV) blood gas values differ from umbilical artery (UA) values, 
more closely resembling adult arterial blood than  umbilical arterial 
blood (UA pH ranges: 7.12 - 7.35 and UV pH range 7.23 - 7.44; base 
deficit ranges: 9.3 to -1.5 for UA and -8.3 to -2.6 for UV).
Comment: In LMICs, a fetal umbilical artery cord pH result may 
not be available.
4. Presence of multisystem organ failure consistent with 
hypoxic-ischaemic encephalopathy: Although the presence 
of organ dysfunction increases the risk of hypoxic-ischaemic 
encephalopathy in the setting of NE, the severity of brain injury 
seen on neuroimaging does not always correlate with the degree of 
injury to other organ systems.
Comment:  Multisystem organ failure as a criterion for NE is 
important as part of the muldimensional and holistic approach to 
establish the likelihood of an acute hypoxic-ischaemic event.
5. Type and timing of contributing factors that are consistent 
with a peripartum or intrapartum event: A sentinel hypoxic or 
ischaemic event occurring immediately before or during labour and 
delivery will include  a ruptured uterus, severe abruptio placentae, 
umbilical cord prolapse, amniotic fluid embolus with coincident 
severe and prolonged maternal hypotension and hypoxaemia, 
maternal cardiovascular collapse and fetal exsanguination from a 
ruptured vasa previa resulting in a massive fetal haemorrhage.
Comment: A sudden hypoxic event of unknown cause, presenting 
as an acute onset of fetal bradycardia in a monitored fetus can result 
in an ‘acute profound picture’ on MRI.
6. Fetal heart rate monitor patterns consistent with a peripartum or 
intrapartum event: A Grade I or Grade II fetal heart rate tracing[67] 
when associated with Apgar scores ≥7 at 5 minutes, normal 
umbilical  arterial and venous cord  pH, or both, makes it unlikely 
that an acute hypoxic-ischaemic event occurred. It is important 
1. Sentinel event
2. Fetal heart rate monitoring supportive
3. Imaging supportive
4. Other proximal or distal factors that can cause CP must be excluded
5. Placental histology 
SQCP or
dyskinetic CP
Yes No
NE
Consider other
aetiology rst
Yes No
Supportive
neonatal signs
Contributing
factors
Consider other 
aetiology
1. Apgar (≥7 at 5 minutes unlikely peripartum hypoxia)
2. Arterial cord pH <7.0 base decit ≥12 mmol/L
3. Imaging
4. Multisystem organ failure
Fig. 1. Algorithm to determine if spastic quadriplegic or dyskinetic cerebral palsy may be the result of an in trapartum hypoxic-ischaemic event. 
(SQCP = spastic quadriplegic cerebral palsy; CP = cerebral palsy; NE = neonatal encephalopathy.)
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to make the distinction between a patient who initially presents 
with an abnormal fetal heart rate pattern and one who develops an 
abnormal fetal heart rate pattern during labour. Category III fetal 
heart tracings are predictive of abnormal fetal acid-base status at 
the time of observation.[67]
Comment: In grade II CTGs, which are indeterminate and account 
for >80% of cases, it is difficult to predict fetal acid-base status at 
observation as they are variable from benign to threatening and 
their interpretation is also subjective, especially with regard to FHR 
variability.[67] A grade II CTG should not be interpreted in isolation 
but in the context  of other clinical parameters. If not, it can lend itself 
to biased interpretation by experts owing to its subjective nature, 
especially as it is often interpreted retrospectively to reconstruct the 
adverse event.
7. Neuroimaging studies – MRI: There are distinct patterns of 
neuroimaging abnormalities recognised in hypoxic-ischaemic 
cerebral injury in the infant born at or beyond 35 weeks of gestation 
which have prognostic value in predicting later neurodevelopmental 
impairments. Despite advances in neuroimaging, the ability to 
precisely time the occurrence of a hypoxic-ischaemic event is still 
limited, depending also on when the MRI is performed.
Comment: As most MRIs for CP are performed late in childhood 
in LMICs, it is unacceptable in these cases for the radiological 
perspective to be viewed in isolation without giving clinical context 
to the radiological findings. Medico-legal decisions should be based 
holistically on the clinical data (antepartum, intrapartum (including 
fetal heart rate anomalies) and neonatal risk factors) and the 
radiology should be interpreted in the context of the clinical scenario.
8. No evidence of other proximal or distal factors that could be 
contributing factors: In the presence of other significant risk 
factors – such as abnormal fetal growth, maternal infection, 
fetomaternal haemorrhage, neonatal sepsis, and chronic placental 
lesions – an intrapartum event as the sole underlying pathogenesis 
of NE becomes much less likely.
Comment: There is enough evidence that antenatal factors could 
initiate a causal pathway for perinatal brain injury and that they, 
possibly together with genetic predispositions to hypoxic-ischaemic 
injury, might make some infants more susceptible than others to the 
stresses of labour and delivery. Fetal priming may play a leading role 
in perinatal brain injury. Priming creates a vulnerability down the 
line and the stresses of the intrapartum process may be the final straw 
in the pathway leading to HIE.
9. Developmental outcome is spastic quadriplegia or dyskinetic CP
Comment: Accepted as is.
10.  Placental histology, where available, should be interpreted in 
the clinical context: Histological findings of chorioamnionitis 
with severe fetal inflammatory response, sentinel lesions (abruptio 
placentae, fetal haemorrhage, umbilical cord occlusions), 
thrombotic or inflammatory lesions of fetal circulation including 
fetal vascular malperfusion,  decreased placental reserve and 
adaptive responses in the placenta, could be significant and 
provide an aetiological basis if interpreted in the overall clinical 
scenario.
Conclusion
1.  CP is a complex medical condition with multiple contributing 
variables and factors involving antenatal factors, intrapartum 
factors, neonatal factors, genetics, toxins, fetal priming, failure 
of neuroscientific autoregulatory mechanisms, abnormal 
biochemistry and abnormal metabolic pathways. Causal pathways 
are often extremely difficult to delineate.
2.  It is simplistic to base causation of CP on only an intrapartum 
perspective with a late or childhood radiological ‘confirmation’ 
using MRI, as is often the practice in medico-legal cases in South 
African courts.
3.  The MRI and CTG modalities that retrospectively attempt to 
determine causation in courts are inadequate when used in 
isolation. Unless a holistic and comprehensive scientific review of 
the case including all contributing factors is taken into account, 
success for plaintiff or defendant currently in a court of law will 
depend on eloquent legal argument rather than true scientific 
causality.
4.  For the present, it is imperative for obstetricians and midwives 
to strive for optimal intrapartum care – appropriate clinical 
practice and monitoring, with careful and complete note-keeping 
including contemporaneous maternal clinical documentation, 
fetal monitoring records and neonatal case records; not doing this 
provides ammunition to attorneys for emotive scenarios in a court 
of law.
5.  Not being able to exclude other causes owing to unavailable 
clinical data does not mean that the aetiology for the CP should 
be defaulted to intrapartum hypoxia. Furthermore, negligent 
intrapartum care, although unfortunate and requiring correction, 
does not equate to causation.
6.  Medico-legal decisions implicating intrapartum hypoxia in NE and 
CP should be based on specific criteria as alluded to above.
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